Jelena Tošović

13PUBLICATIONS
20CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsHealth and ecological risk assessmentWastewater treatment processesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 23, 2026
Discovery of SMD-6346: A Potent, Selective, and Orally Active SMARCA2 Degrader for Targeting SMARCA4-Deficient Human Cancers.

|Mar 23, 2026
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader.

Dimin Wu, Haibin Zhou, Longchuan Bai

|Apr 08, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer".

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

|Jan 02, 2025
Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders.

Lingying Leng, Wenbin Tu, Lin Yang

|Nov 07, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.

Renqi Xu, Haibin Zhou, Longchuan Bai

|Nov 01, 2024
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer.

Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu

Pageof 3

Frequent Collaborators

8 joint publications

Shaomeng Wang

6 joint publications

Rohan Kalyan Rej

6 joint publications

Duxin Sun

4 joint publications

Ranjan Kumar Acharyya